Research News

Drug, Alcohol, Tobacco Use at a Young Age Can Cause Premature Heart Problems

People who start using substances at a younger age have worse health outcomes over the long term, which requires “a nationwide education campaign on the potential long-term damage being done to the cardiovascular system in patients with substance use disorders,” writes Dr. Anthony Orr, Director of Center of Excellence for Cardiovascular Diseases and Sciences at LSUHS.

Read More about Drug, Alcohol, Tobacco Use at a Young Age Can Cause Premature Heart Problems
Dr. Keith Scott Selected as Medical Director of the  LSUHS Office of Clinical Trial Services

Combining his experience not only as a principal investigator on numerous clinical trials but also as a critical care physician for over thirty years, Dr. Scott will provide medical support and oversight for all clinical trials conducted at LSU Health Shreveport.

Read More about Dr. Keith Scott Selected as Medical Director of the LSUHS Office of Clinical Trial Services
‘We’re in the dark’: The U.S. is way behind on testing for dangerous COVID variants

Fortune.com - Even the type of sequencing done in the U.S. has been lacking, some experts say, with much of the effort focused on finding cases of the U.K. variant, rather than casting a wider net for any variant, including ones not previously identified, said Jeremy Kamil, a virologist at Louisiana State University Health Shreveport.

Read More about ‘We’re in the dark’: The U.S. is way behind on testing for dangerous COVID variants (opens in new window/tab)
scientist in lab

Bloomberg.com - Even the type of sequencing done in the U.S. has been lacking, some experts say, with much of the effort focused on finding cases of the U.K. variant, rather than casting a wider net for any variant, including ones not previously identified, said Jeremy Kamil, a virologist at LSU Health Shreveport. “It’s the Wild West,” he said. “Every state, city, county is doing its own thing. It’s a bunch of random cats and no one is trying to herd them.”

Read More about U.S. Falters in DNA Testing to Detect Dangerous Covid Mutations (opens in new window/tab)
Pfizer Offers COVID-19 Shots to Health Workers Who Got Placebo

Bloomberg - On Monday, John Vanchiere, the principal investigator for a trial site at LSU Health Shreveport, emailed 245 participants to let them know the COVID-19 vaccine trial would be slowly unblinded. By Wednesday afternoon, seven placebo recipients got their first shot, all of them health-care workers.

Read More about Pfizer Offers COVID-19 Shots to Health Workers Who Got Placebo (opens in new window/tab)
Pfizer-BioNTech COVID-19 vaccine vial

KSLA 12 - Dr. Robert Rhoads, professor and emeritus chairman of the Department of Biochemistry and Molecular Biology at LSU Health Shreveport, developed key components of the mRNA over years of work. The vaccine uses messenger RNA, or mRNA, which essentially provides instructions to the body on how to fight the novel coronavirus.

Read More about Technology developed at LSU Health Shreveport played key role in COVID-19 vaccine development
COVID-19 vaccine arrives at Ochsner-LSU Health Shreveport

KSLA 12 - “It is gratifying to see LSU Health Shreveport’s contributions to the Pfizer-BioNTech vaccine through licensing of a LSUHS patent to BioNTech for mRNA-stabilizing cap analogs and in serving as the only north Louisiana vaccine trial site. Additionally our numerous COVID-19 clinical trials are providing access to novel therapies reflecting the benefit of having an academic medical center in our community,” shared Dr. G.E. Ghali, Chancellor of LSU Health Shreveport.

Read More about COVID-19 vaccine arrives at Ochsner-LSU Health Shreveport
video clip image

KSLA 12- “If the EVT Lab had not existed, quite frankly, I think we’d be in a much darker place here in the northern part of the state,” said Dr. Chris Kevil, vice chancellor of research and one of the leading minds behind creation of the lab. “The EVT Lab has been fundamental in our ability to monitor COVID infections in patients out in this community."

Read More about Amid dark days of pandemic, LSU Health Shreveport’s Emerging Viral Threat Lab stands as a beacon of hope (opens in new window/tab)
Dr. Quyen Chu - LSU Health Shreveport

Dr. Quyen Chu, Professor of Surgery and Chief of the Division of Surgical Oncology at LSU Health Shreveport, is the lead author of the study set for publication in an upcoming issue of Cancer, a journal of the American Cancer Society. 

Read More about LSUHS study finds increase in earlier diagnosis of breast cancer following Medicaid expansion (opens in new window/tab)
Feist-Weiller Cancer Center building

SHREVEPORT, La. (KSLA) - Cancer patients from across Northwest Louisiana — who are receiving treatment at MD Anderson Cancer Center in Houston — could soon benefit from new trials closer to home.

Read More about ‘It’s a game changer,’ New clinical trials coming to Feist-Weiller Cancer Center (opens in new window/tab)
Focus Fund and MD Anderson Launch Investment Fund to Support Investigational Cancer Therapies

The Feist-Weiller Cancer Center is excited to be a part of the Cancer Focus Fund to bring the latest new cancer clinical trials to our community," said Dr. Chris Kevil, Vice-Chancellor for Research at LSU Health Shreveport. "We are confident our clinical trial facilities, coupled with expanded patient access to clinical trials across north and central Louisiana in partnership with Ochsner Health, will yield promising results for all citizens of Louisiana.

Read More about Focus Fund and MD Anderson Launch Investment Fund to Support Investigational Cancer Therapies
LSU Health Shreveport leads Louisiana in COVID-19 genome sequencing

MSN.com - The Emerging Viral Threat (EVT) Lab at LSU Health Shreveport has now sequenced a total 651 Louisiana SARS-CoV-2 virus genomes making it the largest contributor to date of genetic data on SARS-CoV-2 in the state. 

Read More about LSU Health Shreveport leads Louisiana in COVID-19 genome sequencing (opens in new window/tab)
LSU Health Shreveport Leads Louisiana  in COVID-19 VIRAL GENOME SEQUENCING

The Emerging Viral Threat (EVT) Lab at LSU Health Shreveport has now sequenced a total 651 Louisiana SARS-CoV-2 virus genomes making them the largest contributor to date of genetic data on SARS-CoV-2 in the state. SARS-CoV-2, which is short for ‘Severe Acute Respiratory Syndrome Coronavirus-2,’ is the virus that causes COVID-19, and viral genome sequencing is contributing to a worldwide effort to fight the ongoing pandemic.

Read More about LSU Health Shreveport Leads Louisiana in COVID-19 VIRAL GENOME SEQUENCING